- Home
- TIL vs FTF Comparison
TIL vs FTF Comparison
Compare TIL & FTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- FTF
- Stock Information
- Founded
- TIL 2018
- FTF 2003
- Country
- TIL United States
- FTF United States
- Employees
- TIL N/A
- FTF N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- FTF Finance/Investors Services
- Sector
- TIL Health Care
- FTF Finance
- Exchange
- TIL Nasdaq
- FTF Nasdaq
- Market Cap
- TIL 218.4M
- FTF 261.4M
- IPO Year
- TIL 2021
- FTF N/A
- Fundamental
- Price
- TIL $26.50
- FTF $6.47
- Analyst Decision
- TIL Buy
- FTF
- Analyst Count
- TIL 4
- FTF 0
- Target Price
- TIL $100.33
- FTF N/A
- AVG Volume (30 Days)
- TIL 154.7K
- FTF 153.9K
- Earning Date
- TIL 11-13-2024
- FTF 01-01-0001
- Dividend Yield
- TIL N/A
- FTF 11.45%
- EPS Growth
- TIL N/A
- FTF N/A
- EPS
- TIL N/A
- FTF N/A
- Revenue
- TIL N/A
- FTF N/A
- Revenue This Year
- TIL N/A
- FTF N/A
- Revenue Next Year
- TIL $2.64
- FTF N/A
- P/E Ratio
- TIL N/A
- FTF N/A
- Revenue Growth
- TIL N/A
- FTF N/A
- 52 Week Low
- TIL $6.08
- FTF $5.76
- 52 Week High
- TIL $92.00
- FTF $6.56
- Technical
- Relative Strength Index (RSI)
- TIL 38.29
- FTF 36.87
- Support Level
- TIL $24.31
- FTF $6.51
- Resistance Level
- TIL $37.24
- FTF $6.63
- Average True Range (ATR)
- TIL 4.02
- FTF 0.08
- MACD
- TIL 0.26
- FTF 0.00
- Stochastic Oscillator
- TIL 10.85
- FTF 23.41
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About FTF Franklin Limited Duration Income Trust of Beneficial Interest
Franklin Limited Duration Income Trust is a closed-end investment company based in the United States. It conducts its investment to provide high, current income, with a secondary objective of capital appreciation. To align with its investment objective is to invest in a diversified mix of fixed-income securities. Its portfolio is dominated by considerable investments in high-yield corporate bonds while touching upon other avenues such as senior secured floating rate corporate loans, mortgage-backed securities, commercial mortgage-backed securities, asset-backed securities, common stocks, and other short-term investments.